BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26787778)

  • 1. External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.
    Lennartz CS; Pickering JW; Seiler-Mußler S; Bauer L; Untersteller K; Emrich IE; Zawada AM; Radermacher J; Tangri N; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):609-15. PubMed ID: 26787778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.
    Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E
    JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Ramsay T; Bugeja A; Brown PA; Clark EG; Biyani M; White CA; Akbari A
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1424-1432. PubMed ID: 32928746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the kidney failure risk equation in European CKD patients.
    Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
    Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
    BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
    Kwek JL; Pang HQJ; Li H; Lim WWL; Choo JCJ; Choong HL; Foo MWY; Chan CM
    Singapore Med J; 2022 Jun; 63(6):313-318. PubMed ID: 36043308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
    Ramspek CL; Evans M; Wanner C; Drechsler C; Chesnaye NC; Szymczak M; Krajewska M; Torino C; Porto G; Hayward S; Caskey F; Dekker FW; Jager KJ; van Diepen M;
    J Am Soc Nephrol; 2021 May; 32(5):1174-1186. PubMed ID: 33685974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
    Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
    Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
    Grams ME; Brunskill NJ; Ballew SH; Sang Y; Coresh J; Matsushita K; Surapaneni A; Bell S; Carrero JJ; Chodick G; Evans M; Heerspink HJL; Inker LA; Iseki K; Kalra PA; Kirchner HL; Lee BJ; Levin A; Major RW; Medcalf J; Nadkarni GN; Naimark DMJ; Ricardo AC; Sawhney S; Sood MM; Staplin N; Stempniewicz N; Stengel B; Sumida K; Traynor JP; van den Brand J; Wen CP; Woodward M; Yang JW; Wang AY; Tangri N
    J Am Soc Nephrol; 2023 Mar; 34(3):482-494. PubMed ID: 36857500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.
    Fenton A; Jesky MD; Webster R; Stringer SJ; Yadav P; Chapple I; Dasgupta I; Harding SJ; Ferro CJ; Cockwell P
    PLoS One; 2018; 13(5):e0197043. PubMed ID: 29742142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort.
    Irish GL; Cuthbertson L; Kitsos A; Saunder T; Clayton PA; Jose MD
    Nephrology (Carlton); 2023 Jun; 28(6):328-335. PubMed ID: 37076122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the kidney failure risk equation in a Portuguese cohort.
    da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
    Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort.
    Ramírez Medina CR; Ali I; Baricevic-Jones I; Saleem MA; Whetton AD; Kalra PA; Geifman N
    Clin Proteomics; 2024 May; 21(1):34. PubMed ID: 38762513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A predictive model for progression of chronic kidney disease to kidney failure.
    Tangri N; Stevens LA; Griffith J; Tighiouart H; Djurdjev O; Naimark D; Levin A; Levey AS
    JAMA; 2011 Apr; 305(15):1553-9. PubMed ID: 21482743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.
    Thanabalasingam SJ; Iliescu EA; Norman PA; Day AG; Akbari A; Hundemer GL; White CA
    Kidney Med; 2022 Apr; 4(4):100440. PubMed ID: 35445190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of the KFRE and Grams prediction models for kidney failure and death in a Spanish cohort of patients with advanced chronic kidney disease.
    Gallego-Valcarce E; Shabaka A; Tato-Ribera AM; Landaluce-Triska E; León-Poo M; Roldan D; Gruss E
    J Nephrol; 2024 Mar; 37(2):429-437. PubMed ID: 38060108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race : A Prospective Cohort Study.
    Bundy JD; Mills KT; Anderson AH; Yang W; Chen J; He J;
    Ann Intern Med; 2022 Mar; 175(3):305-313. PubMed ID: 35007146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.